Clinical Trial Update: Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

View source ↗

Summary

A clinical trial update indicating the study evaluating the effects of semaglutide on heart and muscle mass is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ozempic/Wegovy (semaglutide)

Snippet

Sponsor: University of Alberta | Conditions: Type 2 Diabetes, Obesity | Status: RECRUITING